comparemela.com

Foot Infection News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Recce Pharmaceuticals successfully treats deadly burn infections in Phase I/II clinical trial

A Phase I/II clinical trial of Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF)’s topical application against burn wound infections, RECCE® 327 (R327), has.

Know the itch: How to recognise and prevent fungal infections

Contrary to popular belief, not all fungal infections happen during the summer. These infections also thrive during the monsoon season because of the surrounding humidity and wetness. Furthermore, despite the widespread misconception that only children are susceptible to these infections, adults of all ages can contract them.

vimarsana © 2020. All Rights Reserved.